The contribution of Natural Killer Complex loci to the development of experimental cerebral malaria by Hansen, Diana S. et al.
The Contribution of Natural Killer Complex Loci to the
Development of Experimental Cerebral Malaria
Diana S. Hansen1*, Victoria Ryg-Cornejo1,3, Lisa J. Ioannidis1, Chris Y. Chiu1,3, Ann Ly1, Catherine Q. Nie2,
Anthony A. Scalzo4,5, Louis Schofield1,6
1 The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia, 2 Burnet Institute, Melbourne, Victoria, Australia, 3Department of Medical Biology,
The University of Melbourne, Parkville, Victoria, Australia, 4Centre for Experimental Immunology, Lions Eye Institute, Nedlands, Western Australia, Australia, 5Centre for
Ophthalmology and Visual Science, The University of Western Australia, Nedlands, Western Australia, Australia, 6Australian Institute of Tropical Health and Medicine,
James Cook University, Douglas, Queensland, Australia
Abstract
Background: The Natural Killer Complex (NKC) is a genetic region of highly linked genes encoding several receptors
involved in the control of NK cell function. The NKC is highly polymorphic and allelic variability of various NKC loci has been
demonstrated in inbred mice, providing evidence for NKC haplotypes. Using BALB.B6-Cmv1r congenic mice, in which NKC
genes from C57BL/6 mice were introduced into the BALB/c background, we have previously shown that the NKC is a genetic
determinant of malarial pathogenesis. C57BL/6 alleles are associated with increased disease-susceptibility as BALB.B6-Cmv1r
congenic mice had increased cerebral pathology and death rates during P. berghei ANKA infection than cerebral malaria-
resistant BALB/c controls.
Methods: To investigate which regions of the NKC are involved in susceptibility to experimental cerebral malaria (ECM),
intra-NKC congenic mice generated by backcrossing recombinant F2 progeny from a (BALB/c x BALB.B6-Cmv1r) F1
intercross to BALB/c mice were infected with P. berghei ANKA.
Results: Our results revealed that C57BL/6 alleles at two locations in the NKC contribute to the development of ECM. The
increased severity to severe disease in intra-NKC congenic mice was not associated with higher parasite burdens but
correlated with a significantly enhanced systemic IFN-c response to infection and an increased recruitment of CD8+ T cells
to the brain of infected animals.
Conclusions: Polymorphisms within the NKC modulate malarial pathogenesis and acquired immune responses to infection.
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Introduction
Malaria is one the most serious infectious diseases of humans
with ,250 million clinical cases annually. Most cases of severe
disease are caused by the blood stage of Plasmodium falciparum. [1].
Fatalities are associated with various disease syndromes including
respiratory distress, metabolic acidosis, hypoglycaemia, renal
failure, pulmonary oedema and cerebral malaria (CM) [2]. This
disease syndrome, which accounts for nearly 1 million deaths
every year [3] is characterised by seizures and coma. To avoid
clearance in the spleen, mature forms of blood-stage malaria
adhere to vascular endothelial cells. This process, known as
parasite sequestration is thought to induce obstructions in blood
flow resulting in hypoxia and haemorrhages [1] that are associated
with the development of organ-specific syndromes such CM.
Disease-association studies indicate that in addition to parasite
sequestration, inflammatory responses also contribute to severe
disease [4]. High TNF, IFN-c and IL-1b levels have been
associated with disease severity [4]. Inflammatory chemokines
including MIP-1a, MIP-1b [5] and CXCL10 [6,7] have been
found to be associated with increased risk of CM mortality.
Although parasite sequestration is the most common feature of
patients succumbing to CM, post-mortem examination has also
revealed intra and peri-vascular pathology including the presence
of leukocytes within brain blood vessels [8–11]. These findings
suggested that intravascular infiltration of host leukocytes might
also contribute to the pathogenesis of some CM cases.
Much useful evidence on the inflammatory processes contributing
to the induction of CM has been provided by the Plasmodium berghei
ANKA model [12]. Like in humans, P. berghei ANKA parasitised red
blood cells (pRBCs) have been found to bind to brain vascular
endothelial cells [13]. Inflammatory responses mediated by the
cytokines TNF [14] and IFN-c [15] and the chemokine CXCL10
[16] have been shown to contribute to severe malaria in mice.
Several leukocyte populations including macrophages, neutrophils, T
cells, NK cells and platelets have been found in brain blood vessels of
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CM-affected mice during infection [17–21]. From those populations,
CD8+ T cells are highly abundant and were shown to mediate CM in
a perforin-dependent manner [17,21].
Elements of the innate immune system have also been shown to
contribute to the development of ECM [22]. CD1d-restricted
NKT cells have been shown to play a protective role against P.
berghei ANKA-mediated CM in BALB/c mice but induce early
IFN-c production and promote disease in C57BL/6 susceptible
animals [23]. Like NKT cells, NK cells readily secrete IFN-c in
response to malaria in humans [24,25] and mice [26]. Further-
more, NK cells were shown to facilitate the recruitment of
CXCR3+ T cells to the brain of malaria-infected mice in an IFN-
c-mediated manner [19]. More specifically, NK cells stimulate the
dendritic cell (DC)-mediated priming of CD8+ T cells in response
to P. berghei ANKA [27].
NK and NKT cell function is controlled by surface receptors
encoded within a genetic region called NKC [28]. Many of these
genes encode type II integral membrane proteins that have
inhibitory or activation function depending on the presence or
absence of immunoreceptor tyrosine-based inhibitory motifs
(ITIMs) in their intracellular domains. Upon ligation, ITIMs
become phosphorylated and recruit protein tyrosine phosphatases,
which interferes with cell activation. In the mouse, inhibitory
receptors include the Ly49 superfamily and NKG2 molecules,
expressed as heterodimers with CD94. Ly49 receptors interact
with MHC I molecules, and CD94/NKG2 complexes bind to Qa-
1b, a non-classical MHC I receptor. Interaction of these receptors
with their MHC I ligands induces inhibition of cytotoxic activity
by NK cells. Under pathological conditions such as viral infections
or tumors, the expression of MHC I molecules is down-regulated,
resulting in loss of negative regulation by inhibitory receptors, NK
cell activation and killing of target cells [29]. Some members of the
Ly49 family lack ITIMs and have activation function. Stimulation
of activation receptors such as Ly49D [30] and Ly49H [31] leads
to IFN-c secretion and cytotoxic activity. Other activation
receptors encoded within the murine NKC are CD94/NKG2C,
NKG2D and NK1.1. In humans, NK receptors are encoded by 2
regions: the NKC on chromosome 12 and the killer cell Ig-like
receptor (KIR) region on chromosome 19. Control of NK cell
function in humans is mediated by interactions between HLA I
and KIR molecules. Thus mouse Ly49 and human KIR genes are
functional homologues, which illustrates an intriguing example of
convergent evolution [32].
The NKC on mouse chromosome 6 is a polymorphic region.
Allelic variability of loci has been shown in inbred mice providing
evidence for NKC haplotypes [33]. In malaria, C57BL/6 NKC
alleles are associated with disease susceptibility, as congenic
BALB.B6-Cmv1r, in which NKC genes from C57BL/6 mice
were introduced in the BALB/c background showed increased
cerebral pathology, pulmonary oedema, anaemia and death rates
during P. berghei ANKA infection [34], compared to resistant
BALB/c controls. To date, the specific NKC receptors involved in
the induction of malarial pathogenesis have not been identified.
To address this question in this study intra-NKC recombinant
mouse strains bearing small intervals of the C57BL/6 NKC in the
BABL/c background were infected with P. berghei-ANKA. Our
results revealed that alleles at two locations in the NKC contribute
to susceptibility to CM in this model.
Methods
Ethics Statement
This manuscript contains work carried out with experimental
mice. In P. berghei ANKA-infected mice, clinical illness develops
between days 6–10 p.i. During this period, P. berghei-infected mice
were monitored 5 times at 8:00 AM, 11:00 AM, 3:00 PM and 6:00
PM and 10:00PM. Mice developing loss of self-righting reflex were
humanely euthanized by CO2 inhalation or cervical dislocation.
All experiments were performed in compliance with the Walter &
Eliza Hall Institute Animal Ethics Committee requirements. The
Walter & Eliza Hall Institute Animal Ethics Committee has
approved this study.
Mice and infections
Eight to 12-week old BALB/c, C567BL/6, BALB.B6-Cmv1r,
BALB.B6-CT-1, BALB.B6-CT-6, BALB.B6-CT1-2 and BALB.B6-
CT-13 [35] were used throughout the study. All mice were bred in
The Walter & Eliza Hall Institute animal facility. Groups of 10–20
mice were injected intraperitoneally (i.p.) with 16106 freshly
passaged P. berghei-ANKA pRBC. Parasitemia was assessed by
counting 10 microscope fields from Giemsa-stained smears of tail
blood prepared every 2–3 days. Mortality was checked daily. Mice
were judged as developing CM if they displayed neurological signs
such as ataxia, loss of reflex and hemiplegia.
In Vivo bioluminescence imaging
Mice were infected (16105 pRBC, i.v.) with a transgenic P.
berghei-ANKA line expressing luciferase and GFP under the control
of the elongation factor 1-a promoter [36]. Luciferase-expressing
pRBCs were visualized in the brain with an I-CCD photon-
counting video camera and in vivo imaging system (IVIS 100;
Xenogen, Alameda, CA). Bioluminescence generated by luciferase
transgenic parasites in brain tissue was measured according to the
manufacturer’s instructions using the same regions of measure-
ment for all samples being compared.
Flow cytometry
Spleen cells from BALB/c, C57BL/6, BALB.B6-CT-1,
BALB.B6-CT-6, BALB.B6-CT-12 and BALB.B6-CT-13 mice
were incubated with anti-CD16 antibody (Fc-block), washed and
then stained with PE-conjugated anti-CD49b (DX-5) and PE-
CY5-conjugated anti-TCR (H57-597) antibodies. Some samples
were simultaneously stained with other antibodies such as FITC-
conjugated anti-Ly49A (A1), Ly49D (4E5), Ly49G2 (Cwy-e),
Ly49I (YLI-90), anti-NKG2A/C/E (20d5) or anti-NK1.1
(PK136) for 1 h on ice (all antibodies and conjugates are from
BD Pharmingen, San Diego, CA, USA). The cells were then
washed twice, resuspended in PBS and analysed in a FACScalibur
cytofluorometer (BD Biosciences, NJ) using CellQuest software.
Viable lymphocytes were gated by forward and side scatter.
ELISA for IFN-c detection
Ninety-six-well plates were coated with capture antibody (R4-
6A2) by overnight incubation at 4uC in Phosphate Buffer pH 9.
Plates were then blocked with 1% BSA for 1 h at 37uC. Serum
samples were diluted 1/5 and tested in triplicates by overnight
incubation at 4uC. Plates were then incubated for 2 h at 20uC with
the biotinylated antibody (XMG1-2) and then for 1 h with
streptavidin-peroxidase conjugate (Pierce, Rockford, IL). Bound
complexes were detected with tetramethyl-benzidine (KBL,
Gaithersburg, MD) and H2O2. Absorbance was read at 450 nm.
Cytokine concentration was calculated using recombinant IFN-c
for the preparation of standard curves.
Purification and analysis of brain-sequestered leukocytes
Brain-sequestered leukocytes were purified on day 7 p.i with P.
berghei-ANKA as described before [19]. Briefly, euthanized mice
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were perfused to remove circulating leukocytes. Brains were then
removed, crushed in RPMI medium and pushed through a cell
mesh. The tissue extract was centrifuged at 2006g for 10 min and
the pellet was dissolved in RPMI containing 0.05% Collagenase D
(Worthington, Lakewood, NJ) and 2 U/ml DNAase I (Sigma).
After 1 h incubation at 22uC, the mixture was filtered through a
cell strainer, seeded on a 35% Percoll (Amersham Bioscience,
Uppsala, Sweden) cushion and centrifuged at 4006 g for 20 min
at 22uC. The pellet was collected and erythrocytes were lysed with
Tris-NH4Cl Buffer. After washing, recovered cells were incubated
with anti-CD16 antibody, washed and stained with PE-anti-
NK1.1 (PK136), FITC-anti-TCR (H57-597) and PerCP-Cy5.5-
anti-CD8 (53-6.7). After washing, cells were resuspended in PBS
and analysed by flow cytometry.
Statistical analysis
A one-way ANOVA was used for data evaluation. A Tukey’s
multiple comparison post-test was used to evaluate differences
between individual mouse strains. Differences in mortality rates of
P. berghei infected mice were assessed by Cox-Mantel logrank
analysis.
Results
Differential expression of markers NKC in intra-NKC
congenic mice
BALB.B6-Cmv1r mice are a congenic strain in which the NKC
from C57BL6 mice has been introduced into the BALB/c
background [37]. As the NKC encodes several different receptors,
intra-NKC recombinant mouse strains were generated by
backcrossing recombinant F2 progeny from a (BALB/c x
BALB.B6-Cmv1r) F1 intercross to BALB/c mice [35]. These
congenic strains are a valuable tool to facilitate mapping of
phenotypically-defined loci [35]. The genotypes of congenic
strains used in this study are described in Table 1. To determine
the phenotypic properties of NK and NKT cells from wild-type
Figure 1. Differential expression of NKC markers in NK/NKT cells from BALB.B6-CT-1, BALB.B6-CT-6, BALB.B6-CT-12 and BALB.B6-
CT-13 mice. (A) Spleen cells from C57BL6, BALB/c and BALB.B6-CT-1, BALB.B6-CT-6, BALB.B6-CT-12 and BALB.B6-CT-13 mice were stained with anti-
CD49b (DX5) and anti-ab TCR antibodies. The percentage of NK and NKT cells are indicated. (B) The expression of the NKC markers NK1.1, Ly49A,
Ly49D, Ly49G2, Ly49I, and NKG2A/C/E was calculated on all DX5 positive cells from the 6 mouse strains. Representative histograms are shown.
doi:10.1371/journal.pone.0093268.g001
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and congenic mice, spleen cells from BALB/c, C57BL/6
BALB.B6-CT-1, BALB.B6-CT-6, BALB.B6-CT-12 and
BALB.B6-CT-13 mice were stained with antibodies against the
pan NK-NKT cell marker DX-5 and abTCR. Figure 1A shows
that spleens of all mouse strains tested have similar percentages of
both NK and NKT cells. The expression of different NKC
markers was then studied in all DX5 positive splenocytes from the
6 mouse strains. Antibodies directed to C57BL/6 NKC receptors
such as NK1.1, Ly49D, Ly49G2 and Ly49I recognized these
molecules on the surface of cells from wild-type C57BL/6 as well
as BALB.B6-CT-12 mice (Figure 1B). None of these molecules
could be detected in spleen cells from BALB/c wild-type or
BALB.B6-CT-1 mice, which only express C57BL/6 alleles outside
the NKC (Table 1). Recombinations in BALB.B6-CT-6 and
BALB.B6-CT-13 mice divide the NKC interval expressed by the
as BALB.B6-CT-12 strain in 2 regions (Table 1). DX5+ cells from
BALB.B6-CT-6 mice expressed NK1.1 but were unable to be
recognised by antibodies against members of the Ly49 superfam-
ily. In contrast, cells from BALB.B6-CT-13 mice readily expressed
Ly49D, Ly49G2 and Ly49I but did not react with an anti-NK1.1
antibody. Antibodies directed against NKG2A/C/E were able to
detect these molecules on all mouse strains tested, suggesting a
higher homology level (Figure 1B). Thus NK and NKT cells from
intra-NKC congenic mice differ in the expression of NKC markers
such as NK1.1 and members of the Ly49 gene superfamily.
C57BL/6 alleles at two locations in the NKC contribute to
susceptibility to ECM
We have previously shown that BALB.B6-Cmv1r congenic mice
display partial susceptibility to P. berghei ANKA-mediated severe
malaria [34]. To investigate which regions of the NKC are
involved in susceptibility to CM, intra-congenic mouse strains
were infected with P. berghei-ANKA and survival monitored daily.
Consistent with previous observations, BALB.B6-Cmv1r mice
developed CM symptoms and 40% of the animals succumbed to
diseased by day 9 post-infection (p.i.). The strain BALB.B6-CT-12,
which bears most of the C57BL/6 NKC alleles but lacks a more
distal region (defined by the microsatellite markers D6Mit13,
D6Mit25 and D6Mit59) present in the original BALB.B6-Cmv1r
congenic (Table 1), showed significant increased susceptibility to
disease than both BALB/c (p = 0.0009) and BALB.B6-Cmv1r mice
(p = 0.0264), reflected as 78% fatalities (Figure 2A). The increased
penetrance of the susceptibility phenotype in BALB.B6-CT-12
compared to BALB.B6-Cmv1r mice suggests that C57BL/6 loci
present in that distal region of BALB.B6-Cmv1r mice might
contribute to resistance to severe malaria in this model. Similar to
BALB/c wild-type controls, BALB.B6-CT-1 mice that express
BALB/c alleles throughout most of the NKC region (Table 1)
were highly resistant to P. berghei ANKA-mediated CM (Figure 2A).
Recombinations in BALB.B6-CT-6 and BALB.B6-CT-13 mice
split the NKC interval expressed by the BALB.B6-CT-12 strain in
2 regions (Table 1). Unlike BALB.B6-CT-12 mice, which were
nearly as susceptible to disease as C57BL/6 controls, when
BALB.B6-CT-6 and BALB.B6-CT-13 animals were challenged
with P. berghei-ANKA (Figure 2A) they displayed partial suscep-
tibility to ECM (p = 0.0356 between BALB.B6-CT-6 and
BALB.B6-CT-12, p = 0.0037 between BALB.B6-CT-13 and
BALB.B6-CT-12). Together these results suggest that C57BL/6
alleles at two locations in the NKC contribute to susceptibility to
CM in this model.
Parasite burdens were also evaluated at different time points p.i.
Consistent with previous findings with BALB.B6-Cmv1r mice,
parasitemia was not affected by the NKC genotype (Figure 2B). As
P. berghei pRBC accumulate in various target organs, it has been
suggested that peripheral parasitemia might not be an accurate
estimation of parasite densities. To address this issue, intra-NKC
congenic mice were infected with a transgenic P. berghei-ANKA
line that constitutively expresses luciferase [36]. Following luciferin
injection on days 3 and 6 p.i., mice were anesthetised and total
parasite biomass was determined by calculating the biolumines-
cence emerging from living parasites. As expected parasite biomass
increased as the infection developed. No significant differences
were found in bioluminescence levels detected from parasites in
NKC congenic mice (Figure 3 A, B). Thus these results indicate
that control of malarial fatalities by the NKC cells does not
operate through effects on parasite growth rates.
The NKC controls systemic IFN-c in murine severe malaria
IFN-c is a pro-inflammatory cytokine critical for CM patho-
genesis in mice. We have previously found that the NKC
differentially regulates systemic IFN-c levels as well as the
transcription of several IFN-c-inducible genes during ECM [34].
To identify NKC loci responsible for these responses, intra-NKC
congenic mouse strains were infected with P. berghei ANKA and
IFN-c levels were measured in sera collected on day 5 p.i. by
capture ELISA. From all the congenic mouse stains evaluated,
BALB.B6-CT-6 and BALB.B6-CT-12 mice secreted IFN-c levels
as high as those produced by C57BL/6 animals (Figure 4). This
enhanced IFN-c response by BALB.B6-CT-6 and BALB.B6-CT-
12 mice was significantly higher than that obtained in BALB/c
wild-type control mice as well as the CM-resistant BALB.B6-CT-1
congenic strain and BALB.B6-CT-13 animals (Figure 4). Thus
together the data suggest that C57BL/6 alleles located within the
NKC interval expressed by BALB.B6-CT-6 are required for
optimal systemic IFN-c responses to P. berghei ANKA.
C57BL/6 NKC alleles are required for optimal induction of
brain-sequestered CD8+ T cells
The accumulation of CXCR3+ CD8+T cells in brains of P.
berghei ANKA infected mice is a key contributing factor in ECM
development. Previous work demonstrated that NK cells stimulate
the DC-mediated priming of naı¨ve CD8+ T cells in response to P.
berghei ANKA [27] and facilitate the migration of these cells to the
brain of infected mice [19]. To determine if different NKC
receptors modulate this process, BALB.B6-CT-1, BALB.B6-CT-6,
Table 1. Genotypes of intra-NKC congenic strains.
Cmv1r CT-1 CT-6 CT-12 CT-13
D6Mit108 c c c c c
Tnfr1 b c b b c
D6Mit52 b c b b c
Nkrp1a b c b b c
D6Mit135 b c b b c
Cd69 b c b b c
CD94 b c c b b
Ly49a b c c b b
Cmv1 (Ly49h) b c c b b
D6Mit13 b b c c c
D6Mit25 b b c c c
D6Mit59 c c c c c
c: BALB/c allele, b: C57BL/6 allele.
doi:10.1371/journal.pone.0093268.t001
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BALB.B6-CT-12 and BALB.B6-CT-13 mice were infected with P.
berghei ANKA and the percentage and total number of brain-
sequestered CD8+ T cells was determined on day 7 p.i. Consistent
with their increased resistance to ECM, virtually no CD8+ T cells
could be isolated from brains of BALB.B6-CT-1 mice (Figure 5
A,B). In contrast, 40–60% of total the brain-sequestered T cell
pool consisted of CD8+ T cells in congenic mice expressing
C57BL/6 NKC (Figure 5A). From these mice, the highly CM-
susceptible BALB.B6-CT-12 strain had total numbers of brain-
sequestered CD8+ T cells significantly higher than BALB.B6-CT-
1, BALB.B6-CT-6 and BALB.B6-CT-13 mice (Figure 5B). This
level of leukocyte sequestration in BALB.B6-CT-12 mice is similar
to that previously reported in wild-type C57BL/6 animals [19].
BALB.B6-CT-6 and BALB.B6-CT-13 mice displayed intermedi-
ate levels of brain leukocyte sequestration, with absolute numbers
of CD8+ T cells higher than CM-resistant BALB.B6-CT-1
animals, though only reaching significance for BALB.B6-CT-13
mice. Thus together the data suggest that C57BL/6 alleles in two
locations are required for optimal recruitment of CD8+ T cells to
the brain of P. berghei ANKA infected mice.
Discussion
Previous work demonstrated that the NKC is a significant
genetic determinant of murine severe malaria, as congenic
BALB.B6-Cmv1r mice showed increased cerebral pathology,
pulmonary edema and death rates during P. berghei ANKA
infection [23] compared to fully resistant BALB/c wild-type
controls. In this study infection of intra-NKC congenic mice,
generated by backcrossing recombinant F2 progeny from a
(BALB/c x BALB.B6-Cmv1r) F1 intercross to BALB/c mice
[35], revealed that C57BL/6 alleles at two locations in the NKC
contribute to the development of ECM. The increased severity to
malarial disease in intra-NKC congenic mice was not associated
with higher parasite burdens but correlated with a significantly
enhanced systemic IFN-c response and an increased recruitment
of CD8+ T cells to the brain of infected animals.
A large body of evidence indicates that IFN-c plays a central
role in CM pathogenesis [15,38–43]. In vitro studies indicate that
human NK cells produce IFN-c in response to P. falciparum-pRBCs
[24] and that the differential expression of human NK cell
receptors modulates NK cell activation in response to blood stage
malaria [44]. Moreover, the differential expression of the NKC-
encoded and KIR-encoded receptors NKG2A, CD94, CD158a/
KIR2DL1 was found to modulate P. falciparum-mediated IFN-c
responses by cd-T cells [45]. Consistent with those finding, we
found that the differential expression of NKC receptors in mice
modulates IFN-c responses to P. berghei ANKA and susceptibility
to severe disease. Interestingly, although NKC loci at 2 separate
Figure 2. Control of malarial pathogenesis by the NKC. Groups of BALB/c, C567BL/6, BALB.B6-Cmv1r, BALB.B6-CT-1, BALB.B6-CT-6, BALB.B6-
CT1-2 and BALB.B6-CT-13 mice (n = 10–20) were infected with P. berghei ANKA. (A) The percentage survival was monitored daily. (B) Parasitemia was
assessed from Giemsa-stained blood smears. Each point represents the mean of 6–10 samples 6 SD.
doi:10.1371/journal.pone.0093268.g002
Figure 3. Control of malarial pathogenesis by the NKC does not affect total parasite biomass. (A) BALB/c, (B) BALB.B6-Cmv1r, (C) BALB.B6-
CT-1, (D) BALB.B6-CT-6, (E) BALB.B6-CT-12 and (F) BALB.B6-CT-13 were infected with a luciferase-expressing P. berghei ANKA transgenic strain. Whole
body parasite biomass acquired on day 3 p.i is shown. Bioluminescence emerging from living parasites was calculated on days 3 and 6 p.i (G). Each
point represents the mean of 3 samples 6 SD. The experiment is representative of 2 separate infection experiments.
doi:10.1371/journal.pone.0093268.g003
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locations were found to contribute to the development of ECM,
C57BL/6 alleles located within the NKC interval expressed by
BALB.B6-CT-6 appeared to be required for optimal systemic
IFN-c responses to infection. Several activation receptors includ-
ing Ly49D [30], Ly49H [31], NK1.1 [46] and NKG2D [47] have
been described to elicit IFN-c secretion by NK and/or NKT cells
upon stimulation. NK1.1 was found to be readily expressed by NK
cells and NKT cells of BALB.B6-CT-6 congenic mice, raising the
possibility that this receptor might modulate IFN-c responses to
infection. In support of that hypothesis, we have previously shown
that cross-linking of NK1.1 preferentially induces IFN-c and no
IL-4 production by CD1d-restricted NKT cells [23], suggesting a
TCR-independent pathway of pro-inflammatory responses to
infection.
Although initially CD1d-restricted NKT cells appeared to be an
important NKC receptor expressing cell lineage responsible for
the increase susceptibility to disease in malaria-infected BALB.B6-
Cmv1r mice [23], further evidence suggested that IFN-c
production by activated NK cells could also have an impact on
the overall immunological status of BALB.B6-Cmv1r mice,
influencing not only disease outcome but also innate and adaptive
responses to infection [34]. Moreover in fully susceptible C57BL/6
mice, NK cells [19] were found to contribute to the development
of ECM by stimulating the recruitment of CD8+ T cells to the
brain of P. berghei ANKA infected mice. Similarly, the present
study found using intra-NKC congenic mice (BALB.B6-CT-12)
exerting 80% penetrance that NKC loci are required for that
process. Thus the highly susceptibility level of congenic BALB.B6-
CT-12 mice revealed novel aspects in the control of this response.
Figure 4. The NKC controls systemic IFN-c production during
malaria infection. Groups of 4–5 BALB/c, C567BL/6, BALB.B6-CT-1,
BALB.B6-CT-6, BALB.B6-CT-12 and BALB.B6-CT-13 were infected with P.
berghei ANKA. IFN-c levels in sera collected on day 5 p.i. were measured
by capture ELISA. The graph shows pooled data from 2 separate
infections, which gave similar results. **** P,0.0001, between BALB.B6-
CT-12 and BALB/c and between BALB.B6-CT-6 and BALB/c; ***
P,0.0005 between BALB.B6-CT-12 and BALB.B6-CT-1, between
BALB.B6-CT-12 and BALB.B6-CT-13, between BALB.B6-CT-1 and
BALB.B6-CT-6 and between C57BL/6 and BALB/c; ** P,0.005 between
BALB.B6-CT-6 and BALB.B6-CT-13, between C57BL/6 and BALB.B6-CT-1
and between C57BL/6 and BALB.B6-CT-13.
doi:10.1371/journal.pone.0093268.g004
Figure 5. CD8+ T cells accumulate in brains of NKC congenic mice during P. berghei ANKA infection. BALB.B6-CT-1, BALB.B6-CT-6,
BALB.B6-CT-12 and BALB.B6-CT-13 mice were infected with P. berghei ANKA. Brains were collected on day 7 p.i after extensive perfusion of the
euthanised animals. The BSL were isolated, stained anti-TCR and anti-CD8 antibodies and analysed by flow cytometry. The percentage (A) and
absolute number (B) of CD8+ T cells were calculated. Representative dot plots are shown. Each bar represents the mean of 7–8 samples obtained over
2 separate infection experiments that gave similar results 6 SEM, **** P,0.0001 between BALB.B6-CT-12 and BALB.B6-CT-1; ***P,0.0005 between
BALB.B6-CT-12 and BALB.B6-CT-6; ** P,0.01 between BALB.B6-CT-12 and BALB.B6-CT-13; *P,0.05 between BALB.B6-CT-13 and BALB.B6-CT-1.
doi:10.1371/journal.pone.0093268.g005
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IFN-c has been shown to participate in different responses
involved in the development of ECM including, upregulation of
receptors mediating parasite sequestration in the vascular endo-
thelium, induction of CXCR3 chemokines responsible for the
recruitment of T cells to the brain, etc [16,48,49]. Interestingly,
although NKC alleles in the interval expressed by BALB.B6-CT-6
were found to be sufficient for the induction of systemic IFN-c
responses, the infection of this congenic strain resulted only in
partial recruitment of CD8+ T cells to the brain. Similar results
were also found after infection of BALB.B6-CT-13 mice that
express incomplete C57BL/6 NKC intervals. Together these
results are consistent with the notion that at least 2 NKC loci at
different locations mediate different non-redundant responses
required to fully recapitulate this phenotype. Prior to their
CXCR3-mediated recruitment to the brain, the priming of naı¨ve
CD8+ T cells has been shown to be largely mediated by CD8a+
conventional DCs, which appears to be the main subset involved
in cross-presentation of parasite-expressed antigens [20]. Interest-
ingly, NK cells and DCs were shown to participate in a cross-talk
which results in mutual activation whereby NK cells stimulate IL-
12 output by CD8a+ conventional DCs required for optimal CD8+
T cell priming [19]. Further work is required to determine
whether different NKC receptors participate in the induction of
these 2 processes (T cell priming and chemokine secretion)
required for efficient migration of inflammatory leukocytes to the
brain of malaria-infected mice.
The NKC is conserved among species, with syntenic regions
identified in rat and human chromosomes. Similar to our findings
here, the differential expression of human NK cell receptors
modulates NK cell activation in response to P. falciparum pRBC
[44]. Using a rodent infection model, we established that
polymorphisms within NKC loci regulate malarial pathogenesis
and the induction of acquired immune responses to infection.
Despite the important public health problem that human malaria
infections poses worldwide, many immunological and genetic
aspects of this disease are not fully understood. Thus further work
is required to determine whether NKC receptors are associated
with disease severity to malaria in human populations.
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